Inferior Alveolar Nerve Block 

  • Author: Noah S Scheinfeld, MD, JD, FAAD; Chief Editor: Meda Raghavendra (Raghu), MD   more...
 
Updated: Aug 2, 2011
 

Overview

The inferior alveolar nerve block is the most common type of nerve block used for dental procedures. Knowledge of mouth and inferior alveolar nerve anatomy is required to perform the procedure.

See the image shown below.

Injection in proper area of ramus to effect alveolInjection in proper area of ramus to effect alveolar nerve block

The mandibular nerve exits at the base of the skull through the foramen ovale.

The first branch from the main trunk is the nervous spinosus, which runs superiorly through the foramen spinosum to supply the meninges.

The second branch is the first motor nerve, which supplies the medial pterygoid muscle. Inferior to that branch, the mandibular nerve splits into an anterior trunk (both sensory and motor) and a posterior trunk.

The motor component supplies the masseter, temporal, and lateral pterygoid muscles.

The posterior trunk radiates from the auriculotemporal nerve that gives sensory perception to the side of the head and scalp and sends twigs to the external auditory meatus, the tympanic membrane, and the temporomandibular joint. The posterior trunk then almost immediately divides into the lingual nerve and the inferior alveolar nerve.

The sensory trunk is the long buccal nerve that supplies the buccal soft tissue distal to the first molar.

The lingual nerve supplies the anterior two thirds of the tongue and the lingual surface of the mandibular gingiva.

The mandibular nerve sends a branch to the mylohyoid muscle and the anterior belly of the digastric muscle and then enters the mandibular canal. The mandibular nerve furnishes sensation to the following areas:

  • Mandible
  • Buccal gingiva anterior to the first molar
  • Lower lip and the pulps of all the mandibular teeth in that quadrant

The inferior alveolar nerve is the larger branch of the posterior division of the mandibular nerve. The inferior alveolar nerve enters the mandibular foramen in the ramus of the mandible (see the image below) to occupy the inferior alveolar canal in the body of the mandible.

Identifying mandibular ramus Identifying mandibular ramus

When the inferior alveolar nerve approaches the apex of the second bicuspid, it divides into two terminal branches, the mental and the incisive.

A nerve block of the intraoral mandibular or inferior alveolar nerve anesthetizes the following:

  • The body of the mandible and the lower portion of the ramus
  • All mandibular teeth
  • The floor of the mouth
  • The anterior two thirds of the tongue
  • Gingivae on the lingual surface of the mandible
  • Gingivae on the labial surface of the mandible
  • Mucosa and skin of the lower lip and chin

Understanding the underlying anatomy of the pterygomandibular space helps increase the effectiveness of inferior alveolar nerve blocks.[1]

Next

Indications

An inferior alveolar nerve block is required to work in the following areas of the mouth:

  • Mandibular teeth to the midline
  • The anterior two thirds of the tongue
  • The floor of the oral cavity
Previous
Next

Contraindications

Absolute contraindication

  • Hypersensitivity to local anesthetic agents, which occurs in less than 1% of the general population

Relative contraindication

  • History of malignant hyperthermia
Previous
Next

Anesthesia

Various types and quantities of local anesthetic agents have been suggested for an inferior alveolar nerve block.

Monheim in 1961[2] suggested 1.5-2 mL of solution. Prescribing information for articaine (Septocaine) recommends up to 3.4 mL for a nerve block,[3] although Lemay in 1984[4] suggested 3.6 mL. Prescribing information for lidocaine suggests up to 5 mL of lidocaine 2%,[5] whereas Gaum recommends a minimum of 3.6 mL of lidocaine 2% with 1:100,000 concentration of epinephrine for inferior alveolar block anesthesia.[6] Administering less may prove to be ineffective in many cases.

Generally, for temporary relief of pain prior to obtaining definitive dental care, the preferred agent is 0.5% bupivacaine (Marcaine, Sensorcaine) with 1:200,000 epinephrine. This provides 1-3 hours of dental pulp analgesia and 4-9 hours of soft tissue analgesia. Epinephrine prolongs duration of action through vasoconstriction at the injection site, which decreases systemic absorption.

Determining local anesthetic concentrations and dilutions

Concentrations: Drug concentration is expressed as a percentage (eg, bupivacaine 0.5%, lidocaine 1%).

  • Percentage is measured in grams per 100 mL (ie, 1% is 1 g/100 mL [1000 mg/100 mL], or 10 mg/mL)
    • Calculate the mg/mL concentration quickly from the percentage by moving the decimal point 1 place to the right, as follows:
      • Bupivacaine 0.5% = 5 mg/mL
      • Lidocaine 2% = 20 mg/mL

Dilutions: When epinephrine is combined in an anesthetic solution, the result is expressed as a dilution (eg, 1:100,000).

  • 1:100,000 means 1 mg per 100 mL (ie, 0.001%)
  • 1:200,000 means 1 mg per 200 mL (ie, 0.0005%)

Table. Epinephrine Content Examples (Open Table in a new window)

Solution Volume 1:100,000



(1 mg/100 mL)



1:200,000



(1 mg/200 mL)



1 mL0.01 mg0.005 mg
5 mL0.05 mg0.025 mg

Common local anesthetic agents for dental anesthesia

Articaine 4% (Septocaine) with epinephrine 1:100,000

  • Adult total dose ranges for submucosal injection
    • Infiltrative administration: 0.5-2.5 mL (20-100 mg)
    • Nerve block: 0.5-3.4 mL (20-136 mg)
    • Oral surgery: 1-5.1 mL (40-204 mg)
    • Not to exceed 7 mg/kg (0.175 mL/kg)
  • Decrease dose in pediatric patients (>4 y), elderly patients, or those with hepatic impairment; use in children younger than 4 y not recommended

Bupivacaine 0.5% (Sensorcaine)

  • Maxillary and mandibular area for oral surgery
  • Adult total dose range is 1.8 mL to a maximum of 18 mL (9-90 mg)
  • Not to exceed 18 mL (90 mg) per dental sitting
  • Reduce dose in pediatric or elderly patients, those with cardiac disease, those who are debilitated, or those with hepatic impairment

Lidocaine 2% (Xylocaine) with epinephrine 1:100,000 (or 1:50,000 when greater depth and hemostasis are required)

  • Maxillary and mandibular area for oral surgery
  • Adult total dose range for submucosal injection: 1-5 mL (20-100 mg)
  • Children younger than 10 years: 0.9-1 mL (18-20 mg)
  • Maximum dose for adult and pediatric patients
    • Not to exceed 7 mg/kg (with epinephrine)
    • Not to exceed 4.5 mg/kg (without epinephrine)

Mepivacaine 2-3% (Carbocaine, Polocaine)

  • Also available with epinephrine 1:200,000 or levonordefrin 1:20,000; each prolongs duration of action
  • Dental infiltration or nerve block
  • Adult dose range
    • 2% with levonordefrin: 1.8 mL (36 mg)
    • Not to exceed 3 mg/kg or 400 mg in adults
    • 3%: 1.8 mL (54 mg)
    • Not to exceed 3 mg/kg or 400 mg in adults
  • Pediatric dose: Not to exceed 9 mL (ie, 180 mg as the 2% solution or 270 mg as the 3% solution)

Prilocaine 4% (Citanest)

  • Adult dose range: 1-2 mL (40-80 mg)
  • Not to exceed 8 mg/kg or 600 mg within a 2-hour period
  • Not to exceed 1 mL (40 mg) in children younger than 10 years
Previous
Next

Equipment

  • Standard dental equipment should be present.
  • The examination table or chair can be adjusted to accommodate the patient's height.
  • An overhead light of sufficient intensity should be present.
  • Sterile thumb-control syringe
  • Topical anesthetic (in the form of pastes or gels)
  • 2% lidocaine with epinephrine or 0.5% bupivacaine with epinephrine
  • Cotton-tipped applicators to administer topical anesthetic and control bleeding
  • Small-gauge (ga) needles (The longer the needle, the easier the inferior alveolar nerve block is to accomplish.)
    • 1 5/8 inch, 23 ga
    • 1 3/8 inch, 25 ga; some recommend 1 1/8 inch, 27 ga needle
    • 1 3/8 inch, 25 ga (probably the most popular choice of needle)
Previous
Next

Positioning

  • Patients should be placed in a dental chair.
  • The head should be tilted back.
  • The patient should open his or her mouth.
Previous
Next

Technique

The technique is as follows, based on the description of Powell:[7]

  • Apply topical anesthetic to the target area, which is the mucosa lateral to the pterygomandibular raphe but medial to the anterior border of the mandibular ramus and about 6-10 mm above the occlusal plane of the maxillary teeth.
  • Place the thumb of the nondominant hand on the coronoid notch and the index finger just anterior to the ear to stretch the tissues over the injection site, maximizing visibility and minimizing the pain of the injection as depicted below. Holding back cheek Holding back cheek
  • With the anterior ramus technique, palpate the anterior border of the ramus with the thumb and find the greatest concavity, which is the coronoid notch.[6]
  • Orient the syringe so that the barrel is in the opposite corner of the mouth, resting on the premolars.
  • With the anterior ramus technique, use the middle finger and thumb to determine the width of the ramus in its anterior-posterior dimension. Anatomically, the mandibular foramen lies in the middle of the ramus in this dimension. The average width of the ramus, including the thickness of the soft tissue in the coronoid notch, is approximately 35 mm, which is also the length of the needle.[6]
  • Aim toward the index finger and slowly penetrate the mucosa until bone is contacted.
    • Bone is usually contacted within about 2.5 cm.
    • If the attempt does not result in contact with bone, reorient the syringe more laterally and repeat attempt.
  • Withdraw slightly and aspirate.
    • Rotate the bevel of the needle and re-aspirate; if no blood is returned, inject 1.5-2 mL of anesthetic.
    • If aspiration is positive, pull back about 5 mm and redirect slightly, then repeat attempt at aspiration.
  • If the injection fails to result in adequate analgesia, it may safely be repeated 2 additional times.
  • Patients often report mild jaw muscle soreness for 2-3 days following this injection.
Previous
Next

Pearls

  • Anatomic landmarks are important to note.
  • An appropriate needle should be used.
  • Understanding and palpating landmarks is critical in a successful attempt.
Previous
Next

Complications

  • A failure rate of 15-20% is seen, even in experienced hands.
  • With an unsuccessful attempt, the patient experiences pain with no therapeutic benefit.
  • Inadequate anesthesia may also result from the formation of a blood clot due to the traumatized, lacerated, and bleeding vessel. The blood from the formation of a hematoma may dilute the local anesthetic solution. This may weaken the anesthetic effects.
  • Fracture of a dental needle while performing an inferior alveolar nerve block has been reported.[8]
  • Trismus and sensory deficit following resolution of trismus have been reported in 2 patients as delayed complications of inferior alveolar nerve block.[9]
  • Medial pterygoid trismus i.e. myospasm occurring after inferior alveolar nerve block has occurred.[10]
Previous
 
Contributor Information and Disclosures
Author

Noah S Scheinfeld, MD, JD, FAAD  Assistant Clinical Professor, Department of Dermatology, Columbia University College of Physicians and Surgeons; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, and New York Eye and Ear Infirmary; Private Practice

Noah S Scheinfeld, MD, JD, FAAD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Optigenex Consulting fee Independent contractor

Specialty Editor Board

Luis M Lovato, MD  Associate Clinical Professor, University of California, Los Angeles, David Geffen School of Medicine; Director of Critical Care, Department of Emergency Medicine, Olive View-UCLA Medical Center

Luis M Lovato, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Chief Editor

Meda Raghavendra (Raghu), MD  Associate Professor, Interventional Pain Management, Department of Anesthesiology, Chicago Stritch School of Medicine, Loyola University Medical Center

Meda Raghavendra (Raghu), MD is a member of the following medical societies: American Association of Physicians of Indian Origin, American Society of Anesthesiologists, and American Society of Regional Anesthesia and Pain Medicine

Disclosure: Nothing to disclose.

References
  1. Khoury J, Mihailidis S, Ghabriel M, Townsend G. Applied anatomy of the pterygomandibular space: improving the success of inferior alveolar nerve blocks. Aust Dent J. Jun 2011;56:112-21. [Medline].

  2. Monheim, L. Local Anesthesia and Pain Control in Dental Practice. 2nd ed. St. Louis, Mo: Mosby Elsevier, Inc.; 1961.

  3. Articaine (Septocaine) [package insert]. Septodont; May 2006.

  4. Lemay H, Albert G, Hélie P, Dufour L, Gagnon P, Payant L, et al. [Ultracaine in conventional operative dentistry]. J Can Dent Assoc. Sep 1984;50(9):703-8. [Medline].

  5. Lidocaine (Lignospan) [package insert]. Septodont; Accessed: July 30, 2008.

  6. Gaum LI, Moon AC. The "ART" mandibular nerve block: a new approach to accomplishing regional anesthesia. J Can Dent Assoc. Jun 1997;63(6):454-9. [Medline].

  7. Powell SL, Robertson L, Doty BJ. Dental nerve blocks. Toothache remedies for the acute-care setting. Postgrad Med. Jan 2000;107(1):229-30, 233-4, 239-40 passim. [Medline].

  8. Shah A, Mehta N, Von Arx DP. Fracture of a dental needle during administration of an inferior alveolar nerve block. Dent Update. Jan-Feb 2009;1:20-2, 25. [Medline].

  9. Smyth J, Marley J. An unusual delayed complication of inferior alveolar nerve block. Br J Oral Maxillofac Surg. Mar 2009;[Medline].

  10. Wright EF. Medial pterygoid trismus (myospasm) following inferior alveolar nerve block:Case report and literature review. Gen Dent. Jan-Feb 2011;1:64-7. [Medline].

  11. Aggarwal V, Jain A, Kabi D. Anesthetic efficacy of supplemental buccal and lingual infiltrations of articaine and lidocaine after an inferior alveolar nerve block in patients with irreversible pulpitis. J Endod. Jul 2009;7:925-9. [Medline].

  12. Local Anesthetics. In: McEvoy GK. AHFS Drug Information 2006. Bethesda: American Society of Health-System Pharmacists, Inc; 2006.

  13. Aminabadi NA, Farahani RM. The effect of pre-cooling the injection site on pediatric pain perception during the administration of local anesthesia. J Contemp Dent Pract. May 2009;3:43-50. [Medline].

  14. Aminabadi NA, Farahani RM, Oskouei SG. Site-specificity of pain sensitivity to intraoral anesthetic injections in children. J Oral Sci. Jun 2009;2:239-43. [Medline].

  15. Choi EH, Seo JY, Jung BY, Park W. Diplopia after inferior alveolar nerve block anesthesia: report of 2 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Jun 2009;6:e21-4. [Medline].

  16. Gow-Gates GA. Mandibular conduction anesthesia: a new technique using extraoral landmarks. Oral Surg Oral Med Oral Pathol. Sep 1973;36(3):321-8. [Medline].

  17. Malamed S. What's new in local anaesthesia. SAAD Dig. Jan 2009;25:4-14. [Medline].

  18. Ngeow WC, Chai WL. Numbness of the ear following inferior alveolar nerve block: the forgotten complication. Br Dent J. Jul 2009;1:19-21. [Medline].

  19. Wiener RC, Crout RJ, Sandell J, Howard B, Ouassa L, Wearden S, et al. Local anesthetic syringe ergonomics and student preferences. J Dent Educ. Apr 2009;4:518-22. [Medline].

Previous
Next
 
Holding back cheek
Identifying mandibular ramus
Injection in proper area of ramus to effect alveolar nerve block
empty para to satisfy content model
empty para to satisfy content model
Table. Epinephrine Content Examples
Solution Volume 1:100,000



(1 mg/100 mL)



1:200,000



(1 mg/200 mL)



1 mL0.01 mg0.005 mg
5 mL0.05 mg0.025 mg
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.